SOUTH SAN FRANCISCO, Calif. — November 4, 2025 — Leads & Copy — Aligos Therapeutics, Inc. (Nasdaq: ALGS) will present at two investor conferences: the Jefferies London Healthcare Conference on November 17, 2025, at 3:00pm GMT, and the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025, at 2:00pm ET.
The presentations will be accessible on the “Investors” page of Aligos’ website, with replays available for at least 30 days.
Aligos Therapeutics, Inc. (NASDAQ: ALGS) aims to improve patient outcomes by developing therapies for liver and viral diseases, including chronic hepatitis B virus (HBV) infection, obesity, MASH, and coronaviruses.
Jordyn Tarazi, Vice President, Investor Relations & Corporate Communications, +1 (650) 910-0427, jtarazi@aligos.com; and Jake Robison, Vice President, Inizio Evoke, Jake.Robison@inzioevoke.com are available for media inquiries.
Source: Aligos Therapeutics
